What Makes Olopatadine USP Related Compound B So Important in Pharma Research?
The pharmaceutical world is extremely precise. Every molecule, every impurity, and every trace substance can influence a product’s success or failure. That’s why Olopatadine USP Related Compound B is so critical in today’s pharma analysis. It might be a relatively insignificant impurity itself, but in safety, in quality, and in regulatory approval, it plays anything but a small part.
Listed in the product category of Impurity Standards and product subcategory of Olopatadine, the compound has emerged into the scientific community through method validation, impurity profiling, and stability analysis. If you are developing antihistamine products or an analytical method, then the compound is mandatory on your agenda.
Understanding of Olopatadine USP Related Compound
Chemically defined as Olopatadine N-oxide, Olopatadine USP Related Compound B is a structurally related impurity to the parent compound Olopatadine. The CAS number is 173174-07-7 and the molecular formula is C₂₁H₂₃NO₄.
You will often find it in an experiment involving oxidative stress or photodegradation. The substance is often present in minute levels but is obligated to be detected and quantified by regulatory bodies like the US Pharmacopoeia (USP), regardless of how minute the trace.
It usually presents as a white to off-white solid. Due to its sensitivity to temperature and light, it's stored at controlled low temperatures, often –20°C, to retain stability during analysis.
Why Is It Critical in Research and Compliance?
1. Meeting Global Regulatory Standards
The pharmaceutical market is regulated by stringent impurity levels. Formulations of olopatadine have to show that their impurities are within accepted levels and contain a compound like the Olopatadine USP Related Compound B. This is important to avoid lagging in approval or even having products recalled.
Accordingly, a certified reference standard of impurity of this compound is required in the process of dossier submission, quality control and bioequivalence.
2. Analytical Method Validation Support
Developing a replicable and reliable analysis method? You will be asked to demonstrate specificity. That is where Olopatadine USP Related Compound B enters. This is applied to differentiate peaks, verify retention times, and adjust the detection method.
Most often, High Performance Liquid Chromatography (HPLC), LC-MS, or UV spectroscopy procedures are used to analyse it.
3. Enabling Stability and Forced Degradation Studies
Oxidative breakdown of olopatadine preferentially forms this compound. By tracking levels of it over time, scientists may determine how environmental conditions influence drug quality. It is also used to approximate the shelf life of a product.
Its detection in forced degradation experiments helps to establish the method to be stability-indicating. This is a key consideration at regulatory submission.
4. Contributing to Toxicological Risk Assessment
Even though Olopatadine USP Related Compound B is possibly present in very low concentration, its probable toxicity necessitates re-evaluation. The regulatory authorities now insist on having full safety information even for inactive moieties. Quantifying and controlling this impurity are not only wise but essential.
Common Issues Faced in Research Labs
Low solubility: It’s slightly soluble in methanol and alcohol, requiring heat or specific solvents during sample prep.
Storage: Incorrect storage conditions can degrade the compound, making results unreliable.
Supply: Many labs face issues in sourcing certified, high-purity standards. This causes delays in method validation and stability reporting.
Conclusion
Olopatadine USP Related Compound B (CAS 173174-07-7) plays a crucial role in each olopatadine pharmaceutical group. It has an impact on submission to regulatory agencies, analytical reliability, and even final product stability.
For authentic impurity standards requirements, look no further than Chemicea. With an ISO and GMP certified facility, Chemicea has been a leading provider of pharmaceutical reference standards for more than 7 years.
If streamlining validation activities or maximising regulatory audit readiness in the lab is of interest to you, then contact Chemicea today.
